How does clinical trial efficacy work (simply put)?

Post date: 2020-12-02 13:05:54
Views: 169
Confused about the data provided on the recent COVID studies, and why they mean vaccines were judged to be 95% effective

The Pfizer and Moderna press releases (Pfizer's linked here) provide three main pieces of data: the number of trial participants, the number of participants who contracted the virus, and the number of participants contracting the virus who were in the control group, receiving a placebo. (Apologies for any mistakes in terminology or anything else I'll be making here.)

So for Pfizer's trial, there were more than 43,000 participants, 170 of them contracting COVID, and 8 of them were in the vaccine group, meaning 162 were in the placebo group. 8/162 is ~5%.

The press releases don't say that this is why the vaccines are judged to be 95% effective, though papers like the Washington Post connect the dots. But how is this not the wrong way to judge effectiveness? Wouldn't the right way be to say 162 out of 16,200, e.g., taking the placebo contracted it, and that's 1%, and 8 of let's say 16,200 receiving the vaccine contracted it, and that's 5% of 1%, meaning the vaccine is 95% effective?
Number of Comments
Please click Here to read the full story.
 
Other Top and Latest Questions:
Qualcomm reports earnings, revenue beat and issues strong forecast
Stifel upgrades this fertilizer manufacturer following earnings beat
Tariffs face an uncertain future after Supreme Court hearing. Here are the potential market impacts
Family offices make fewer deals but still flock to AI startup mega-rounds
Trump nuclear power investment in Westinghouse could lead to IPO with U.S. government as shareholder
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 
Here are Thursday's biggest analyst calls: Nvidia, Apple, Caterpillar, Qualcomm, Robinhood, Snap & more
Why Thanksgiving shoppers might get shock from seeing turkey prices this season
Matthew McConaughey, Ryan Reynolds-backed password manager tops $400 million in ARR on AI tail winds
Trump may have to refund the tariffs. These stocks would benefit most